查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1468096

2024-2032 年按物种、抗毒液类型、作用方式、最终用户和地区分類的抗毒液市场报告

Anti-Venom Market Report by Species, Anti-venom Type, Mode of Action, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球抗蛇毒血清市场规模达11.695亿美元。蛇咬伤和蝎子蜇伤发生率的上升、政府有利倡议的实施以及行业的持续创新是推动市场发展的一些关键因素。

抗毒液，也称为毒液抗血清，是指用于治疗动物（包括蛇、蜘蛛、蝎子和某些海洋生物（例如水母或锥螺））毒咬伤或蜇伤的药物。它是透过从犯罪动物身上提取毒液，然后将少量毒液注射到马、绵羊或山羊等动物体内来获得的，这些动物的免疫系统会产生抗体，这些抗体被收集和纯化以产生抗毒液。抗蛇毒血清可以中和毒素并抵消毒液的影响，防止它们引起危及生命的併发症，例如呼吸衰竭或器官损伤。根据病史、检查以及地理、临床和病理因素，它在全球广泛用于治疗有毒咬伤和蜇伤。

抗毒液市场趋势：

世界各地，特别是农村和热带地区以及农业工人和猎人中的毒咬伤和蜇伤病例的增加，是推动市场成长的主要因素之一。除此之外，消费者对预防蛇咬伤的重要性以及以实惠的价格轻鬆获得产品的重要性的认识不断提高，正在为市场创造良好的前景。此外，政府实施的众多打击蛇咬伤倡议，例如教育和培训计划，以及对新型抗蛇毒产品研发（R＆D）活动的​​大量投资，都有助于市场成长。除此之外，随着对动物性蛋白质的需求不断增长，面临蛇咬伤风险的牲畜和其他动物数量增加，这反过来又为市场带来了有利可图的成长机会。同时，旅行和探索异国情调目的地（例如岛屿、沙漠、丛林和狩猎）的日益流行，使游客面临被蛇咬伤和遭遇其他有毒动物的风险，这是另一个重要的成长诱导因素。此外，生物技术和医疗保健行业的许多技术进步以及製造技术的持续创新改进，使得生产更有效和高效的抗蛇毒产品成为可能，对市场成长产生了积极影响。除此之外，各种快速蛇毒检测试剂盒的推出正在推动市场的发展，这些试剂盒利用快速酵素免疫分析法，透过从咬伤部位、尿液、血浆、血液或其他组织和体液中采集的样本来检测和识别蛇毒。

本报告回答的关键问题

  • 2023年全球抗蛇毒血清市场规模有多大？
  • 2024-2032年全球抗蛇毒血清市场的预期成长率为何？
  • COVID-19 对全球抗蛇毒血清市场有何影响？
  • 推动全球抗蛇毒血清市场的关键因素是什么？
  • 全球抗蛇毒血清市场依物种划分是怎样的？
  • 全球抗蛇毒血清市场以抗蛇毒血清类型划分是怎样的？
  • 根据作用方式，全球抗蛇毒血清市场的细分如何？
  • 基于最终用户的全球抗蛇毒血清市场的细分如何？
  • 全球抗蛇毒血清市场的重点区域有哪些？
  • 全球抗蛇毒血清市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球抗蛇毒血清市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依品种

  • 蛇
    • 市场走向
    • 市场预测
  • 蝎
    • 市场走向
    • 市场预测
  • 蜘蛛
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按抗毒血清类型

  • 多价抗蛇毒血清
    • 市场走向
    • 市场预测
  • 单价抗蛇毒血清
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按行动模式

  • 细胞毒性
    • 市场走向
    • 市场预测
  • 神经毒性
    • 市场走向
    • 市场预测
  • 血液毒性
    • 市场走向
    • 市场预测
  • 心臟毒性
    • 市场走向
    • 市场预测
  • 肌毒
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 医院
    • 市场走向
    • 市场预测
  • 诊所
    • 市场走向
    • 市场预测
  • 门诊手术中心
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Bharat Serums and Vaccines Limited (BSV)
    • Boehringer Ingelheim International GmbH
    • Boston Scientific Corporation
    • CSL Limited
    • Haffkine Bio-Pharmaceutical Corporation Limited
    • Incepta Pharmaceuticals Limited
    • Merck & Co. Inc.
    • Merck KGaA
    • MicroPharm Limited
    • Pfizer Inc.
    • Rare Disease Therapeutics Inc.
Product Code: SR112024A5147

The global anti-venom market size reached US$ 1,169.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,003.5 Million by 2032, exhibiting a growth rate (CAGR) of 6% during 2024-2032. The rising incidences of snake bites and scorpion stings, the implementation of favorable government initiatives, and ongoing innovations in the industry represent some of the key factors driving the market.

Anti-venom, also known as venom antiserum, refers to a type of medication used to treat the effects of venomous bites or stings from animals, including snakes, spiders, scorpions, and certain marine creatures such as jellyfish or cone snails. It is obtained by extracting venom from the offending animal and then injecting small amounts of the venom into animals, such as horses, sheep, or goats, whose immune systems produce antibodies that are harvested and purified to create anti-venom. Anti-venom neutralizes the toxins and counteracts the effects of the venom, preventing them from causing life-threatening complications such as respiratory failure or organ damage. It is extensively adopted across the globe in treating venomous bites and stings, depending on their history, examination, and geographic, clinical, and pathologic factors.

Anti-Venom Market Trends:

The rise in cases of venomous bites and stings across the world, particularly in rural and tropical regions and among agricultural workers and hunters, represents one of the prime factors driving the market growth. Besides this, the escalating consumer awareness of the importance of snake bite prevention and easy product availability at an affordable price is creating a favorable outlook for the market. Moreover, the implementation of numerous government initiatives to combat snake bites, such as education and training programs, and intensive investments in research and development (R&D) activities of new anti-venom products are contributing to the market growth. In addition to this, with the rising demand for animal-based protein, there is an increase in the number of livestock and other animals at risk of snake bites, which, in turn, is presenting remunerative growth opportunities for the market. Concurrent with this, the rising popularity of traveling and exploring exotic destinations, such as islands, deserts, jungles, and safaris, that puts tourists at risk of snake bites and other venomous animal encounters is acting as another significant growth-inducing factor. Furthermore, numerous technological advancements in the biotechnology and healthcare industries and ongoing innovative improvements in manufacturing technology, allowing for the production of more effective and efficient anti-venom products, are positively impacting the market growth. Apart from this, the launch of various rapid snake venom detection kits, which utilize a rapid enzyme immunoassay to detect and identify snake venom through samples taken from bite sites, urine, plasma, blood, or other tissues and body fluids, is propelling the market forward.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global anti-venom market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on species, anti-venom type, mode of action and end user.

Species Insights:

Snake

Scorpion

Spider

Others

The report has provided a detailed breakup and analysis of the anti-venom market based on the species. This includes snake, scorpion, spider, and others. According to the report, snake represented the largest segment.

Anti-venom Type Insights:

Polyvalent Anti-venom

Monovalent Anti-venom

A detailed breakup and analysis of the anti-venom market based on the anti-venom type has also been provided in the report. This includes polyvalent and monovalent anti-venom. According to the report, polyvalent anti-venom accounted for the largest market share.

Mode of Action Insights:

Cytotoxic

Neurotoxic

Haemotoxic

Cardiotoxic

Myotoxic

Others

The report has provided a detailed breakup and analysis of the anti-venom market based on the mode of action. This includes cytotoxic, neurotoxic, haemotoxic, cardiotoxic, myotoxic, and others. According to the report, neurotoxic represented the largest segment.

End User Insights:

Hospitals

Clinics

Ambulatory Surgical Centers

A detailed breakup and analysis of the anti-venom market based on the end user has also been provided in the report. This includes hospitals, clinics, and ambulatory surgical centers. According to the report, hospitals accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for anti-venom. Some of the factors driving the North America anti-venom market included the increasing incidence of snake bites, the introduction of numerous favorable government initiatives, and the thriving travel and tourism sector.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global anti-venom market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Bharat Serums and Vaccines Limited (BSV), Boehringer Ingelheim International GmbH, Boston Scientific Corporation, CSL Limited, Haffkine Bio-Pharmaceutical Corporation Limited, Incepta Pharmaceuticals Limited, Merck & Co. Inc., Merck KGaA, MicroPharm Limited, Pfizer Inc., and Rare Disease Therapeutics Inc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. What was the size of the global anti-venom market in 2023?
  • 2. What is the expected growth rate of the global anti-venom market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global anti-venom market?
  • 4. What are the key factors driving the global anti-venom market?
  • 5. What is the breakup of the global anti-venom market based on the species?
  • 6. What is the breakup of the global anti-venom market based on the anti-venom type?
  • 7. What is the breakup of the global anti-venom market based on the mode of action?
  • 8. What is the breakup of the global anti-venom market based on the end user?
  • 9. What are the key regions in the global anti-venom market?
  • 10. Who are the key players/companies in the global anti-venom market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Anti-venom Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Species

  • 6.1 Snake
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Scorpion
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Spider
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Anti-venom Type

  • 7.1 Polyvalent Anti-venom
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Monovalent Anti-venom
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Mode of Action

  • 8.1 Cytotoxic
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Neurotoxic
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Haemotoxic
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cardiotoxic
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Myotoxic
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Ambulatory Surgical Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Bharat Serums and Vaccines Limited (BSV)
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Boehringer Ingelheim International GmbH
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Boston Scientific Corporation
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 CSL Limited
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Haffkine Bio-Pharmaceutical Corporation Limited
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Incepta Pharmaceuticals Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Merck & Co. Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Merck KGaA
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 MicroPharm Limited
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Rare Disease Therapeutics Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Anti-venom Market: Major Drivers and Challenges
  • Figure 2: Global: Anti-venom Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Anti-venom Market: Breakup by Species (in %), 2023
  • Figure 5: Global: Anti-venom Market: Breakup by Anti-venom Type (in %), 2023
  • Figure 6: Global: Anti-venom Market: Breakup by Mode of Action (in %), 2023
  • Figure 7: Global: Anti-venom Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Anti-venom Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Anti-venom (Snake) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Anti-venom (Snake) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Anti-venom (Scorpion) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Anti-venom (Scorpion) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Anti-venom (Spider) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Anti-venom (Spider) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Anti-venom (Other Species) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Anti-venom (Other Species) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Anti-venom (Polyvalent Anti-venom) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Anti-venom (Polyvalent Anti-venom) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Anti-venom (Monovalent Anti-venom) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Anti-venom (Monovalent Anti-venom) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Anti-venom (Cytotoxic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Anti-venom (Cytotoxic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Anti-venom (Neurotoxic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Anti-venom (Neurotoxic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Anti-venom (Haemotoxic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Anti-venom (Haemotoxic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Anti-venom (Cardiotoxic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Anti-venom (Cardiotoxic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Anti-venom (Myotoxic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Anti-venom (Myotoxic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Anti-venom (Other Mode of Actions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Anti-venom (Other Mode of Actions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Anti-venom (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Anti-venom (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Anti-venom (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Anti-venom (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Anti-venom (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Anti-venom (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: North America: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: North America: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: United States: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: United States: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Canada: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Canada: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Asia-Pacific: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Asia-Pacific: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: China: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: China: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Japan: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Japan: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: India: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: India: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: South Korea: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: South Korea: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Australia: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Australia: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Indonesia: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Indonesia: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Others: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Others: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Europe: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Europe: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Germany: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Germany: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: France: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: France: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: United Kingdom: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: United Kingdom: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Italy: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Italy: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Spain: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Spain: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Russia: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Russia: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Latin America: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Latin America: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Brazil: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Brazil: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Mexico: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Mexico: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Others: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Others: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Middle East and Africa: Anti-venom Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Middle East and Africa: Anti-venom Market: Breakup by Country (in %), 2023
  • Figure 87: Middle East and Africa: Anti-venom Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Global: Anti-venom Industry: SWOT Analysis
  • Figure 89: Global: Anti-venom Industry: Value Chain Analysis
  • Figure 90: Global: Anti-venom Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Anti-venom Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Anti-venom Market Forecast: Breakup by Species (in Million US$), 2024-2032
  • Table 3: Global: Anti-venom Market Forecast: Breakup by Anti-venom Type (in Million US$), 2024-2032
  • Table 4: Global: Anti-venom Market Forecast: Breakup by Mode of Action (in Million US$), 2024-2032
  • Table 5: Global: Anti-venom Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Anti-venom Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Anti-venom Market: Competitive Structure
  • Table 8: Global: Anti-venom Market: Key Players